Zanamivir aqueous solution in severe influenza: A global Compassionate Use Program, 2009

Zanamivir aqueous solution in severe influenza: A global Compassionate Use Program, 2009–2019

Author:

Wang‐Jairaj Jie¹,Miller Irene²,Joshi Aditya³,Jayabalan Tharaka²,Peppercorn Amanda⁴,Zammit‐Tabona Peter⁵,Oliver Amanda⁶^ORCID

Affiliation:

1. Clinical Science, R&D GSK Brentford Middlesex UK

2. Safety and Medical Governance, R&D Global Medical GSK Brentford Middlesex UK

3. Development Biostatistics GSK Bangalore India

4. Clinical Development GSK Boston Massachusetts USA

5. Global Clinical Science and Delivery, R&D GSK Collegeville Pennsylvania USA

6. Global Health R&D GSK Brentford Middlesex UK

Funder

GlaxoSmithKline Australia

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

Reference29 articles.

1. World Health Organization.Influenza (seasonal)2018;https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal). Accessed 15 June 2020.

5. Shionogi Pharma Co.Full prescribing information of Xofluza (Baloxavir marboxil).2019.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献